Table 2 Main characteristics of studies on Lin28B and cancer prognosis
First author | Case nationality | Region | Age, years | Included number | Malignant disease | Detected sample | Analysis method | Survival analysis |
|---|---|---|---|---|---|---|---|---|
Hsu, 2015 | Chinese Taiwan | Asia | 53.80mean | 140 | EOC | Tissue | IHC | OS/PFS |
Tu, 2015 | USA | North America | NA | 595 | CRC | Tissue | IHC | OS |
Wang, 2015 | China | Asia | 46.30mean | 58 | OSCC | Tissue | IHC | OS |
Hu, 2014 | China | Asia | 50.00mean | 97 | GC | Tissue | IHC | OS |
Pang, 2014 | China | Asia | 56.90mean | 149 | Colon cancer | Tissue | IHC | OS/RFS |
Cheng, 2013 | Chinese Taiwan | Asia | 60.00mean | 96 | HCC | Blood | qRT-PCR | RFS |
Wu, 2013 | China | Asia | 60.00mean | 72 | OSCC | Tissue | IHC | OS/DFS |
Diskin, 2012 | USA | North America | 1.42median | 87 | Neuroblastoma | Tissue | qRT-PCR | OS |
Hamano, 2012 | Japan | Asia | 65.00mean | 137 | OC | Tissue | IHC | OS/DFS |
King, 2011 | USA | North America | 66.40mean | 88 | Colon cancer | Tissue | Microarrays | OS/RFS |
Lu, 2009 | USA | North America | 57.90mean | 211 | EOC | Tissue | qRT-PCR | OS/PFS |